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Abstract  Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is the most often cancer occurs in the head and neck. Early 
stage NPC is difficult to diagnose clinically, most NPC patients have been diagnosed in advanced stages. The 
study presents a case of early-stage NPC with the symptoms of recurrent nosebleeds and headache which can 
be early symptom to suspect NPC. 
Case report: We reported a case of 27-year-old woman patient with chief complaints recurrent nosebleeds 
since 2 months ago frequently one to two times a week. Patients also complained of mild headaches, but 
getting better by taking a rest and patient also had a history of tinnitus since 2 month ago. The patient has a 
habit of consuming salted fish and preservative food since childhood. Based on his history of illness, physical 
examination, imaging, and histopathology, we concluded that he was diagnosed with Nasopharyngeal 
Carcinoma T1N0M0, and the patient are going to reffered to North Sumatera or central java to get 
radiotherapy. 
Conclusion: Early stage of nasopharyngeal cancer is a rare condition at Aceh, the fastest we found early 
stages will increased survival rate. 
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1. CASE REPORT 
A 27-year-old woman came to the Ear Nose Throat Head and Neck 
policlinic - dr. Zainal Abidin General Hospital Banda Aceh in January 2021. 
The patient complained of recurrent nosebleeds that had been experienced 
since the previous 2 months, nosebleeds is recurrent with a frequency of one 
to two times per week. The blood that comes out is not much, sometimes 
there are only blood spots when the patient blows his nose. In addition, 
patient also complained of mild headaches and getting better by taking a rest, 
but headaches often recur. Headache is felt especially on the forehead. Apart 
from that the patient also had a history of tinnitus. History of double eye 
vision and of lumps around the neck was denied. 
The patient has a habit of consuming salted fish quite often, besides 
that the patient also likes to consume preservative foods such as instant 
noodles since childhood. There is no family member who has a history of 
cancer. Anterior rhinoscopy examination found a minimal clot in the left 
nasal cavity, and no other abnormalities were seen. 
On 04th February 2021 the patient underwent a rigid 
nasopharyngoscopy examination at policlinic to evaluate the cause of 
recurring nosebleeds. Before that, the patient underwent a screening of 
COVID-19 and the result of RT- PCR SARS-cov-2 was negative. 
 
 
Picture 1. Rigid nasopharyngoscopy on February 04th 2021 
 
 
The result of Rigid nasopharyngoscopy found there was  a thickening 
at lateral left nasopharyngeal surface, especially around the fossa of 
rosenmüller. We did informed consent to performed a nasopharyngeal 
biopsy to determine the histopathology of thickening area. The biopsy was 
performed in Ear Nose Throat Head and Neck policlinic under local 
anasthesia using biopsy forceps and 0 degrees rigid telescope and obtained 
1 mm of tissue from the lateral left nasopharyngeal wall. Then the 
speciment was sent to Pathology Anatomy Laboratory at Dr. Zainoel 
Abidin Hospital, after a week we got the histopathogical result was non 
keratinizing squamous cell carcinoma. 
On the 15th February 2021, we performed an HRCT of the 
nasopharynx with contrast and we have a result two day after. 
  
Picture 2. CT scan of the nasopharyng using contrast showed thickening 
of the nasopharyngeal wall 
The nasopharyngeal wall was thickened on a CT scan and there is no 
other visible mass and hipervascularisation. Based on history, physical 
examinations and all diagnostic procedure such as CT scan nasopharynx 
with contras, Rigid nasopharyngoscopy plus biopsy, chest X-rays and 
histophatologic result, we diagnosed a patient with nasopharyngeal 
carcinoma T1N0M0. We informed her to reffer to North sumatera or 
central java to have radiotherapy. We still do not have a central 














At the pharyngeal recess or Fossa of rosenmüller, the highest incidence 
of NPC inside the nasopharynx is found (82 percent), 12 percent occur in the 
midline and 6-10 percent of patients displayed normal endoscopic presence 
of nasopharyngeal mucosa. Fossa of Rosenmüller, which is superior and 
posterior to the Eustachian tube elevation. This fossa of Rosenmüller, which 
is coated with mixed stratified epithelium and ciliated epithelium with 
regions of a discontinuous attenuated reticular epithelium, is the lateral 
extension of the nasopharynx. So-called reticular epithelium in the 
nasopharyngeal regions, NPC can emerge from a special transitional 
epithelium and, It is likely that the origin of the cells could be [1]. In this case 
the tumour did not appeared exophiticly but highly suspicious as asimetric 
surface of both lateral surface of nasopharingeal wall.  
Generally, in Indonesia especially Aceh it is very rare we found early 
stages of NPC. Dr. Zainoel Abidin General Hospital Banda Aceh as a top 
refferal hospital in Aceh always received advanced diseases of NPC from 
all district at Aceh. As we reported before in 2016-2017, The characteristic 
of NPC at dr. Zainoel Abidin General Hospital Banda Aceh the most 
frequent was age ranged 41-60 years (44%), and incidence is higher in 
males than females and all of the subjects were locally advanced and 
advanced diseases. No one of them came in early stages [2]. Other study 
reported about nasopharyngeal carcinoma in childhood, the age ranged 12-
16 years were 47%, and with the average age was 17.2 years [3]. The latest 
study reported in 2019, The youngest patient is 13-year-old and the oldest 
is 79-year-old. Most common average age are between 36-65-year-old and 
none of all as an early stage [4]. Zhu yi in China reported Up to 87.6% of 
enrolled young patients with NPC were in an advanced stage (stage III or 
IV), and less than 15 % of patients can be diagnosed at an early stage and   
Tobing in Medan  reported only 10% of NPC patients are likely to be 
diagnosed early at stage I. [5, 6]. 
Sign and Symptoms of nasopharyngeal carcinomas frequently present 
with one or more of 4 groups of symptoms. They are consisting of otologic 
symptoms such as deafness and tinnitus, a small tumor in the fossa of 
rosenmüller of the nasopharynx may cause eustachian tube Nasal signs 
such as nasal obstruction, epistaxis, and discharge (these symptoms are 
related to the presence of tumor mass in the nasopharynx). Cranial nerve 
paralysis, normally 5th and 6th cranial nerves, which is connected to the 
superior tumor extension contributing to skull base erosion, the patient 
may experience headache, diplopia, facial pain, and masses of numbness 
and neck. Nasal signs such as nasal obstruction, epistaxis, and discharge 
(these symptoms are related to the presence of tumor mass in the 
nasopharynx). Cranial nerve paralysis, normally 5th and 6th cranial nerves, 
which is connected to the superior tumor extension contributing to skull 
base erosion, the patient may experience headache, diplopia, facial pain, 
and masses of numbness and neck. Severe headache is a symptom that 
arises due to the spread of the tumor to the anterior nerve groups are: N.III, 
NV, and NVI called the petrosphenoid syndrome. whereas parotidean 
syndrome occurs due to the spread of the tumor posterolaterally towards 
the parafarynx and the pterygopalatine fossa which enters the jugular 
foramen. nerves affected in this syndrome are the posterior brain nerve 
group, namely: NVII to NXII. In this patient there were no symptoms of 
parotidean syndrome. Headache from patient is not a sign of parotidean 
syndrome. [6, 7]  
Nasal obstruction, epistaxis, and discharge are all signs of nasal 
obstruction (these symptoms are related to the presence of tumor mass in 
the nasopharynx). The patient may experience headache, diplopia, facial 
pain, and masses of numbness and neck with cranial nerve paralysis, 
usually 5th and 6th cranial nerves, which is related to the superior tumor 
extension leading to skull base erosion. endoscope, however, is inferior to 
that of the rigid endoscope. This case presented recurrent nosebleed and 
mild headache.  [8, 9]. 
Computed tomography (CT) has long been utilized for staging 
nasopharyngeal carcinoma specially to detect skull base tumor 
involvement with lytic or sclerotic lesions. However, now, in some centers, 
MRI has replaced the use of CT for primary and nodal staging. MRI is 
considered to be an accurate examination to diagnose nasopharyngeal 
carcinoma. Subclinical nasopharyngeal carcinomas that are missed at 
endoscopy can be detected by MRI. Nasopharyngeal carcinomas in MRI 
usually present with intermediate signal intensity on T2 weighted images 
and low signal intensity on T1 weighted images. When suspicion of early-
stage nasopharyngeal carcinoma arises, MRI can be an option if 
endoscopic examination does not reveal the expected signs. CT is still 
needed in radiotherapy planning [10, 11]. 
We have sufficient facilities to worked up of NPC patient, but not the 
modality of treatment. Histopathology result is still as a gold standart for 
diagnosis of NPC. In Addition, It remains unclear the precise contribution 
of EBV infection to NPC growth. In NPC tumor cells, the presence of 
monoclonal EBV episomes suggests that virus infection precedes the 
clonal expansion of the population of malignant cells. However, the 
absence of epithelial EBV infection from individuals at high risk of 
developing nasopharyngeal carcinoma in normal nasopharyngeal biopsies 
indicates that epithelial infection may not be the initiating event of virus-
associated carcinogenesis. IEBV infection as defined by in situ 
hybridization to the EBER RNAs is present in high-grade (severe 
dysplastic and carcinoma in situ) preinvasive lesions in the nasopharynx 
but not in low-grade disease or histologically normal nasopharyngeal 
epithelium. Both high-grade and carcinoma in situ lesions bear monoclonal 
EBV genomes.n high-grade (severe dysplastic and carcinoma in situ) 
preinvasive lesions in the nasopharynx but not in low-grade disease or 
histologically normal nasopharyngeal epithelium, EBV infection as 
identified by in situ hybridization to the EBER RNAs is found. 
Monoclonal EBV genomes are borne by both high-grade and carcinoma in 
situ lesions. [12, 13]. 
There are three pathological subtypes of nasopharyngeal carcinoma: 
keratinizing squamous, non-keratinizing, and basaloid squamous, 
according to the World Health Organization.According to the World Health 
Organization, there are three pathological subtypes of nasopharyngeal 
carcinoma: keratinizing squamous, non-keratinizing, and basaloid 
squamous. Non-keratinizing nasopharyngeal carcinoma can be divided 
into differentiated and undifferentiated tumours. The non-keratinizing 
subtype constitutes most cases in endemic areas (>95%) and is 
predominantly associated with Epstein-Barr virus (EBV) infection. EBV 
can be detected in the tumor cells of almost all nonkeratinizing carcinoma 
but rarely in keratinizing nasopharyngeal carcinoma [12-14]. In addition, 
almost 100 percent of WHO type III is associated with Epstein Barr Virus 
(EBV) infection, in particular. High IgG and IgA antibody responses to 
viral capsid antigen (VCA), early antigen (EA), and Epstein Barr Nuclear 
antigen (EBNA) suggest this (EBNA). 2-10 years before the appearance of 
the tumor, increased IgA NPC character antibodies can be identified. This 
occurs as a result of reactivation of EBV infection [15-17]. In our hospital 
we were not routinly doing the test for EBV. This patient show Non-
keratinizing nasopharyngeal carcinoma as the result from histopathological 
examination, but there is no more explaination about type of differentiation 
from the tissues. 
 We routinly performed HRCT of nasopharinx with contrast to 
determine the stage of NPC at least for Tumour level (T) and locoregional 
metastasis (N) as well as laboratory test and ultrasonography and chest x-
ray to looking for distant metastasis (M). We used TNM system from 
AJCC 8th edition 2017. The 2021 National Comprehensive Cancer 
Network (NCCN) guideline is used for the most recent staging system and 
management of head and neck malignancies [18]. 
Treatment and prognosis of nasopharyngeal cancer depend on the type 
of tissue, histological characteristics, and TNM staging. Patients with 
T1N0M0 nasopharyngeal carcinoma should be treated with definitive 
radiotherapy alone, including elective Radio therapy to the neck. 
Radiotherapy alone is the standard treatment for early stage 
nasopharyngeal carcinoma and five-year overall survival rate of 84 to 90% 
can be achieved even with the use of conventional treatment technique. In 
general, patients with stage I and II nasopharyngeal carcinoma are treated 
by radiation only, whereas stage III and stage IV patients are treated by 
concurrent chemotherapy and radiation. In addition, evidence suggests that 
patients diagnosed with stage IV nasopharyngeal carcinoma with locally 
advanced disease may be better controlled by neoadjuvant cisplatin 
followed by chemoradiation. In this case, the patient was planned refer to 
hospital that can performed radiation therapy. For T1N0 patients, 
radiotherapy alone is given with a radical dose of 66-70 Gy daily Monday-
Friday in 6-7 weeks [14]. 
Early-stage T1 and T2 nasopharyngeal cancers have very high (> 
95%) 5-year locoregional control rates. The 5year overall survival rates are 
significantly lower, 70-75%, emphasizing the propensity of these lesions to 
metastasize [18]. 
Since we do not have central radiotherapy, all the patient who had 
diagnosed as NPC with advanced stages, they underwent induction 
chemotherapy at Dr. Zainoel Abidin General Hospital Banda Aceh and if 
possible, for them to continued radiotherapy in out of city. 
A thorough examination and awareness of nasopharyngeal carcinomas 
early signs and symptoms will made it possible for clinicians to detect an 
early-stage nasopharyngeal carcinoma. Stage, WHO type and age at 
diagnosis are important prognostic factors for survival for nasopharyngeal 
carcinoma patients. With early diagnosting, we can deliver immediate 
theraphy and will increase survival rate. Usually patient come to ENT 
specialist on advanced stage where complaints from patient are increasing 
and management to treat patient more complex [18]. 







However, the early diagnosing of nasopharyngeal carcinoma can be 
difficult to determine because the post nasal space is relatively inaccessible 
examination, because of that the anamnesis must be clear. Early cancers of 
the nasopharynx produce minimal and trivial symptoms that may be 
neglected by the patients and undetected by physicians. Moreover, 
sometimes patients consult doctors of different specialties who have lack 
experience in managing nasopharyngeal carcinoma [15, 16]. Usually 




This case bring us new hope that awareness of early symptom of NPC  
have arised at community based. The patient came from west Aceh where 
geographically about 300 kilometres far away  from Banda Aceh. The 
Insurance from government also give contribution to get more easier to 
medical access. 
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